2 Cheap Canadian Stocks I’d Buy This December

Value-seeking investors can consider gaining exposure to small-cap stocks such as Equinox Gold and BioSyent.

| More on:
Workers use a microscope to do medical research in a modern laboratory.

Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

While the stock market is hovering near all-time highs, investors can still buy and hold quality companies trading at a discount to their intrinsic value. In this article, I have identified two undervalued Canadian stocks you can buy today and generate outsized returns in 2025 and beyond. Let’s dive deeper.

Created with Highcharts 11.4.3BioSyent + Equinox Gold PriceZoom1M3M6MYTD1Y5Y10YALL28 Nov 201927 Nov 2024Zoom ▾Jan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '240www.fool.ca

BioSyent stock

BioSyent (TSXV:RX) is a specialty pharmaceutical company with a market cap of $133.6 million. It sources, acquires, develops, and sells healthcare products in Canada and other international markets. Its products include iron supplements and lubricants for various procedures, such as endoscopy and proctoscopy.

In the last 12 months, BioSyent has reported revenue of $34.5 million, an increase of 12% year over year. Its revenue has almost tripled from $12.2 million in 2014. Moreover, the company reports a consistent profit due to a healthy gross margin of 79.4% and an operating margin of 24%. A debt-free balance sheet allows BioSyent to report a free cash flow of $6.7 million in the last four quarters, indicating a margin of 19.4%.

Notably, the healthcare stock has reported positive earnings per share for 57 consecutive quarters. Analysts tracking the Canadian company project earnings to expand to $0.63 per share in 2024 and $0.9 per share in 2026, up from $0.53 per share in 2023.

BioSyent’s revenue is forecast to surpass $45 million in 2026. Given a free cash flow margin of 20%, BioSyent might end 2026 with an FCF of $9 million. Priced at 20 times forward FCF, BioSyent stock could gain 35% over the next 12 months.

BioSyent also pays shareholders an annual dividend of $0.18 per share, indicating a forward yield of 1.5%. The payout has increased by 12% in the past year. Investors can expect its dividend growth to continue as the company has a payout ratio of just 31%.

Equinox Gold stock

Valued at a market cap of $2.6 billion, Equinox Gold (TSX:EQX) is engaged in acquiring, exploring, and developing mineral properties. It explores gold and silver deposits with mining interests in Brazil, the U.S., and Mexico.

In Q3 of 2024, Equinox Gold realized US$2,461 per ounce on the 174,000 ounces it sold, bringing in US$428 million in total sales. The increase in sales was attributed to higher production and rising gold prices. The Greenstone mine, under construction last year, contributed 44,000 ounces in Q3 and will be a key driver of sales over the next 12 months.

Higher sales and a focus on cost optimization allowed Equinox to report US$101 million in income from mine operations, up from $76 million in the year-ago period.

While gold prices have rallied over 30% in 2024, the TSX stock has seen a 25% uptick in share prices this year. Higher commodity prices will allow Equinox Gold to end 2025 with an adjusted earnings per share of US$1, up from US$0.24 in 2024 and US$0.07 in 2023.

Priced at 7.8 times forward earnings, Equinox Gold stock is cheap and could be part of your equity portfolio at current prices. Analysts remain bullish on EQX stock and expect it to gain 36% according to consensus price target estimates.

Should you invest $1,000 in BCE right now?

Before you buy stock in BCE, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and BCE wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends BioSyent. The Motley Fool has a disclosure policy.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Stock Market

tsx today
Stock Market

TSX Today: Why Canadian Stocks Could Fall on Thursday, April 3

TSX stocks may come under pressure today as sharp commodity declines and Trump’s sweeping new tariffs spark fresh concerns over…

Read more »

stock research, analyze data
Stock Market

Why I Keep Investing in Canadian Stocks Despite Market Fluctuations 

Market fluctuations are an opportune time to buy value stocks. Some good Canadian stocks are on sale, encouraging you to…

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Friday, April 2

Trump’s trade tariffs-related remarks could reintroduce volatility to TSX today, especially if he signals a hardline stance.

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Tuesday, April 1

Any updates related to trade policy will remain on TSX investors’ radar today as we come close to the implementation…

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Monday, March 31

TSX stocks may face increased volatility this week as Trump’s reciprocal tariffs are set to kick in.

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Friday, March 28

Alongside any trade policy news, U.S. personal consumption expenditure data will stay in focus for TSX investors today.

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Thursday, March 27

TSX stocks may remain volatile today as investors digest the implications of U.S. trade policy shifts and await fresh cues…

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Wednesday, March 26

Despite lingering macro concerns and trade uncertainties, the TSX Composite has climbed 4.5% over the past 10 sessions.

Read more »